However, the lack of extensive human clinical trials means long-term safety data in humans remains limited
AOD9604 is a laboratory research material used to examine cellular and molecular pathways associated with lipid metabolism under controlled experimental conditions
From a theoretical pharmacological standpoint, combining a peptide with putative lipolytic activity (AOD 9604) with a potent triple incretin receptor agonist (retatrutide) could potentially amplify metabolic effects but this is speculative and raises the possibility of compounding adverse effects with no safety data to guide dosing or monitoring
Research demonstrates benefits for IBS, leaky gut, NSAID-induced damage [11] , chronic gut inflammation, and food sensitivities
RFK Jr February 2026 announcement: HHS Secretary Robert F
It was engineered to isolate the segment of the HGH molecule associated with fat metabolism while leaving out the parts that influence IGF-1 and insulin receptor activity